Natera (NTRA) Competitors $174.37 +2.21 (+1.28%) As of 01:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NTRA vs. HIMS, GH, RDNT, OPCH, SHC, BTSG, WGS, CON, PRVA, and SGRYShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Hims & Hers Health (HIMS), Guardant Health (GH), RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Natera vs. Its Competitors Hims & Hers Health Guardant Health RadNet Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Privia Health Group Surgery Partners Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends. Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 9.63% compared to Natera's net margin of -12.89%. Hims & Hers Health's return on equity of 26.26% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-12.89% -22.22% -15.03% Hims & Hers Health 9.63%26.26%13.06% Which has higher valuation & earnings, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B14.10-$190.43M-$1.91-91.29Hims & Hers Health$1.48B7.68$126.04M$0.8062.75 Does the media favor NTRA or HIMS? In the previous week, Natera and Natera both had 30 articles in the media. Natera's average media sentiment score of 1.34 beat Hims & Hers Health's score of 0.54 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 22 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 9 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 6 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, NTRA or HIMS? Natera has a beta of 1.68, meaning that its share price is 68% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.14, meaning that its share price is 114% more volatile than the S&P 500. Do analysts recommend NTRA or HIMS? Natera currently has a consensus price target of $194.00, indicating a potential upside of 11.26%. Hims & Hers Health has a consensus price target of $38.92, indicating a potential downside of 22.47%. Given Natera's stronger consensus rating and higher possible upside, analysts clearly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 3.06Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 Do insiders & institutionals believe in NTRA or HIMS? 99.9% of Natera shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.6% of Natera shares are owned by insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryNatera and Hims & Hers Health tied by winning 8 of the 16 factors compared between the two stocks. Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.93B$7.51B$5.72B$10.27BDividend YieldN/A2.80%5.72%4.60%P/E Ratio-91.2974.7875.7726.39Price / Sales14.1036.14493.51166.99Price / CashN/A24.0725.8129.90Price / Book19.277.9612.856.30Net Income-$190.43M$241.92M$3.29B$270.30M7 Day Performance-1.14%-0.01%0.37%1.98%1 Month Performance6.96%2.69%4.74%6.16%1 Year Performance34.47%2.90%68.88%27.93% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera3.5552 of 5 stars$174.37+1.3%$194.00+11.3%+36.1%$23.93B$1.70B-91.294,434Positive NewsHIMSHims & Hers Health2.6502 of 5 stars$49.77+2.8%$38.92-21.8%+226.0%$11.25B$1.48B62.211,637GHGuardant Health4.0763 of 5 stars$60.17+0.1%$58.24-3.2%+104.5%$7.50B$739.02M-17.962,021Insider TradeRDNTRadNet3.4614 of 5 stars$71.99+0.8%$76.80+6.7%+10.6%$5.54B$1.83B-359.9311,021Positive NewsOPCHOption Care Health4.8731 of 5 stars$29.59+1.7%$35.75+20.8%-12.8%$4.80B$5.00B23.678,088Positive NewsSHCSotera Health2.1706 of 5 stars$15.91+1.9%$16.00+0.6%-3.4%$4.52B$1.10B198.903,000High Trading VolumeBTSGBrightSpring Health Services2.4208 of 5 stars$25.48+5.6%$25.67+0.7%+96.2%$4.51B$12.57B82.2035,000High Trading VolumeWGSGeneDx2.5831 of 5 stars$129.33-2.4%$101.63-21.4%+222.3%$3.72B$305.45M2,586.601,200Positive NewsCONConcentra Group Holdings Parent3.1103 of 5 stars$22.79-1.3%$27.50+20.7%-8.0%$2.92B$1.90B19.1511,250Positive NewsPRVAPrivia Health Group4.4165 of 5 stars$23.59+1.3%$28.58+21.2%+17.9%$2.90B$1.90B214.471,140Positive NewsSGRYSurgery Partners3.1584 of 5 stars$22.08-1.9%$33.00+49.5%-30.3%$2.83B$3.11B-15.4415,000Positive News Related Companies and Tools Related Companies HIMS Competitors GH Competitors RDNT Competitors OPCH Competitors SHC Competitors BTSG Competitors WGS Competitors CON Competitors PRVA Competitors SGRY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NTRA) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NTRA Stock Alerts